Kymera Therapeutics COO Chadwick Jeremy G Buys and Sells Shares
ByAinvest
Wednesday, Mar 25, 2026 5:19 pm ET1min read
KYMR--
Kymera Therapeutics, Inc. [KYMR] has announced that Chadwick Jeremy G, Chief Operating Officer, has executed several transactions on March 23, 2026, and March 25, 2026. On March 23, Mr. G purchased 84,400 shares at $29.64 per share and sold 22,756 shares at $76.73 per share, as well as 52,975 shares at $77.21 per share, 8,214 shares at $78.40 per share, 6,105 shares at $79.87 per share, and 1,200 shares at $80.05 per share. On March 25, Mr. G purchased 24,727 shares at $29.64 per share and sold an equal number of shares at $80.26 per share.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet